Nipro PharmaPackaging announced the launch of its innovative D2F (Direct-to-Fill) glass vials which are powered by Stevanato Group’s advanced EZ-fill technology, offering a high-quality ready-to-use (RTU) solution.
Recipharm and Exela Pharma Sciences announced an exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States.
Ahead of CPHI Milan, EPM spoke to Hayley Crowe, executive vice president and general manager of Ecolab's Global Life Sciences sector, to discuss the company's approach to addressing the growing demand of cell and gene therapies (C>s).
Matthias Mikkelsen, Fill/Finish Systems Specialist, Flexicon Liquid Filling, Watson-Marlow Fluid Technology Solutions discusses how you can design your processes to be compliant with the new Annex 1 guidelines.
Bristol Myers Squibb have announced a $400 million investment in their Dublin 15 Cruiserath Campus towards the build and design of a Sterile Drug Product facility.
As we close off this year at EPM, we look back at one of our standout interviews with Alison Dillon, Director of Marketing Communications and Strategy at Sharp.
The European Commission’s revision of its Good Manufacturing Practices (GMP) Annex 1 for sterile drug products will have implications for pharmaceutical companies that market their sterile drug products in the EU.
Roberto Zerbi, global life sciences business development manager at industrial technology manufacturer Watlow, explains the challenge comes that come from developing the EudraLex Volume 4 Annex 1 guidance.
The pharmaceutical sector is built on a philosophy of progress. The constants of innovation, research and experimentation sustain a steady stream of scientific and technological discoveries aimed at improving processes,
SCHOTT focuses on possible fill-and-finish solutions based on increased usage of pre-washed and pre-sterilised drug containers compared with traditional filling concepts that work with purchasing non-sterile, so-called ‘bulk’ containers.
Fabio Bertacchini, Senior Director of Product, Proposal and Technical Account Management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges.
